Cited by 1,967Cancer-related Molecular PathwaysCell death mechanisms and regulationPI3K/AKT/mTOR signaling in cancer

The DOI matches its Crossref record; 168 of the 169 references it cites were found in a registry or an index.

The first 30 years of p53: growing ever more complex.

Open access

Levine, Arnold J., Oren, Moshe·2009·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Thirty years ago p53 was discovered as a cellular partner of simian virus 40 large T-antigen, the oncoprotein of this tumour virus. The first decade of p53 research saw the cloning of p53 DNA and the realization that p53 is not an oncogene but a tumour suppressor that is very frequently mutated in human cancer. In the second decade of research, the function of p53 was uncovered: it is a transcription factor induced by stress, which can promote cell cycle arrest, apoptosis and senescence. In the third decade after its discovery new functions of this protein were revealed, including the regulation of metabolic pathways and cytokines that are required for embryo implantation. The fourth decade of research may see new p53-based drugs to treat cancer. What is next is anybody's guess.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nrc2723

Cites

168 of 168 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“More recently, induction of cellular senescence was identified as an additional mechanism whereby p53 curbs neoplastic processe”
p53, guardian of the genome
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Self-citation
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Self-citation
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765

Flagged first, then by citations

Show all 169 references

1 of the 169 references couldn’t be matched to a known paper.

Sorted by citations

Items 901–1,000 of 1,002

Jmjd5 functions as a regulator of p53 signaling during mouse embryogenesis
Ishimura, A., Terashima, M., Tange, S., & Suzuki, T. (2015) · Cell and Tissue Research · doi:10.1007/s00441-015-2276-7 · Cited by 19
Murine Double Minute 2 siRNA and wild-type p53 gene therapy interact positively with zinc on prostate tumours in vitro and in vivo
Gu, J., Wang, B., Liu, Y., Zhong, L., Tang, Y., Guo, H. B., Jiang, T., Wang, L., Li, Y., & Cai, L. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2013.12.027 · Cited by 19
Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis
Wang, H., Yu, P., Bai, J., Zhang, J., Kong, L., Zhang, F., Du, G., Pei, S., Zhang, L., Jiang, Y., et al. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/468537 · Cited by 19
IL-7Rα deficiency in p53null mice exacerbates thymocyte telomere erosion and lymphomagenesis
Kibe, R., Zhang, S., Guo, D., Marrero, L., Tsien, F., Rodrı́guez, P. C., Khan, S., Zieske, A. W., Huang, J., Li, W., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2011.203 · Cited by 19
A Fish-Specific Transposable Element Shapes the Repertoire of p53 Target Genes in Zebrafish
Micale, L., Loviglio, M. N., Manzoni, M., Fusco, C., Augello, B., Migliavacca, E., Cotugno, G., Monti, E., Borsani, G., Reymond, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046642 · Cited by 20
The p53 cofactor Strap exhibits an unexpected TPR motif and oligonucleotide-binding (OB)–fold structure
Adams, C. J., Pike, A., Maniam, S., Sharpe, T., Coutts, A., Knapp, S., Thangue, N. L., & Bullock, A. (2012) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1113731109 · Cited by 20
Insulin Receptor Tyrosine Kinase Substrate Enhances Low Levels of MDM2-Mediated p53 Ubiquitination
Wang, K., Chen, G., Shen, H., Li, T., Chen, F., Wang, Q.-W., Wang, Z., Han, Z., & Zhang, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023571 · Cited by 20
miR-26a regulates mouse hepatocyte proliferation via directly targeting the 3' untranslated region of CCND2 and CCNE2
Zhou, J., Ju, W., Yuan, X., Zhu, X., Wang, D.-P., & He, X.-S. (2016) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(15)60383-6 · Cited by 19
The effect of ribosomal protein S15a in lung adenocarcinoma
Zhang, Y., Zhang, G., Li, X., Li, B., & Zhang, X. (2016) · PeerJ · doi:10.7717/peerj.1792 · Cited by 19
Toxic Effects of Methylated Benzo[a]pyrenes in Rat Liver Stem-Like Cells
Trilecová, L., Krčková, S., Marvanová, S., Pěnčíková, K., Krčmář, P., Neča, J., Hulinková, P., Pálková, L., Cigánek, M., Milcová, A., et al. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200049x · Cited by 19
Control of Nucleotide Metabolism Enables Mutant p53’s Oncogenic Gain-of-Function Activity
Schmidt, V. A., Nagar, R., & Martinez, L. A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122759 · Cited by 20
Bombyx mori homolog of tumor suppressor p53 is involved in apoptosis-mediated antiviral immunity of B. mori cells infected with nucleopolyhedrovirus
Makino, S., Hamajima, R., Saito, A., Tomizaki, M., Iwamoto, A., Kobayashi, M., Yamada, H., & Ikeda, M. (2018) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2018.02.009 · Cited by 19
Total ginsenosides of Chinese ginseng induces cell cycle arrest and apoptosis in colorectal carcinoma HT‑29 cells
Li, T., Sun, W., Dong, X., Yu, W., Cai, J., Yuan, Q., Shan, L., & Efferth, T. (2018) · Oncology Letters · doi:10.3892/ol.2018.9192 · Cited by 19
miR‑125a is upregulated in cancer stem‑like cells derived from TW01 and is responsible for maintaining stemness by inhibiting p53
Chen, J., Ouyang, H., An, X., & Liu, S. (2018) · Oncology Letters · doi:10.3892/ol.2018.9587 · Cited by 19
Ubiquinol-cytochrome C reductase core protein II promotes tumorigenesis by facilitating p53 degradation
Han, Y., Wu, P., Wang, Z., Zhang, Z., Sun, S., Liu, J., Gong, S., Gao, P., Iwakuma, T., Molina‐Vila, M. Á., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.002 · Cited by 19
Roles of cellular heterogeneity, intrinsic and extrinsic noise in variability of p53 oscillation
Wang, D.-G., Wang, S., Huang, B. Y., & Liu, F. (2019) · Scientific Reports · doi:10.1038/s41598-019-41904-9 · Cited by 20
Evaluation of TP53/PIK3CA mutations using texture and morphology analysis on breast MRI
Moon, W. K., Chen, H.-H., Shin, S. U., Han, W., & Chang, R. (2019) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2019.08.026 · Cited by 19
Selenium nanoparticles act as an intestinal p53 inhibitor mitigating chemotherapy-induced diarrhea in mice
Sun, F., Wang, J., Wu, X., Yang, C. S., & Zhang, J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104475 · Cited by 19
Non-disruptive mutation in TP53 DNA-binding domain is a beneficial factor of esophageal squamous cell carcinoma
Huang, M., Jin, J., Zhang, F., Wu, Y., Xu, C., Ying, L., & Su, D. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.142 · Cited by 18
Gene expression profiling analysis of deoxynivalenol-induced inhibition of mouse thymic epithelial cell proliferation
Li, D., Ye, Y., Deng, L., Ma, H., Fan, X., Zhang, Y., Yan, H., Deng, X., Li, Y., & Ma, Y. (2013) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2013.06.002 · Cited by 19
Carbonic Anhydrase Inhibitors Induce Developmental Toxicity During Zebrafish Embryogenesis, Especially in the Inner Ear
Matsumoto, H., Fujiwara, S., Miyagi, H., Nakamura, N., Shiga, Y., Ohta, T., & Tsuzuki, M. (2017) · Marine Biotechnology · doi:10.1007/s10126-017-9763-7 · Cited by 19
p53 promotes its own polyubiquitination by enhancing the HDM2 and HDMX interaction
Medina‐Medina, I., Martínez‐Sánchez, M., Hernández‐Monge, J., Fåhræus, R., Müller, P., & Olivares‐Illana, V. (2018) · Protein Science · doi:10.1002/pro.3405 · Cited by 19
P53 protein overexpression in de novo acute myeloid leukemia patients with normal diploid karyotype correlates with FLT3 internal tandem duplication and worse relapse‐free survival
Assi, R. E., Gur, H. D., Loghavi, S., Konoplev, S. N., Konopleva, M. Y., Daver, N. G., Tashakori, M., Kadia, T. M., Routbort, M. J., Salem, A., et al. (2018) · American Journal of Hematology · doi:10.1002/ajh.25255 · Cited by 19
The Evolution of Tumors in Mice and Humans with Germline p53 MutationsPreprint
Levine, A. J., Chan, C. S., Dudgeon, C., Puzio‐Kuter, A. M., & Hainaut, P. L. (2015) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2015.80.027631 · Cited by 19
Self-citation
PIG3 Regulates p53 Stability by Suppressing Its MDM2-Mediated Ubiquitination
Jin, M., Park, S., Kim, S. W., Kim, H., Hyun, J. W., & Lee, J.-H. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.086 · Cited by 17
Long noncoding RNAs: p53’s secret weapon in the fight against cancer?
Dangelmaier, E. A., Lazar, S. B., & Lal, A. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000143 · Cited by 17
Association of TP53 Mutations with Response to Anlotinib Treatment in Advanced Non-Small Cell Lung Cancer
Fang, S., Cheng, W., Zhang, M., & Yang, R. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s257052 · Cited by 18
Overexpression of p53 accelerates puberty in high-fat diet–fed mice through Lin28/let-7 system
Chen, T., Chen, C., Wu, H., Chen, X., Xie, R., Wang, F., Sun, H., & Chen, L. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220961320 · Cited by 18
The p53 signaling pathway of the large yellow croaker ( Larimichthys crocea ) responds to acute cold stress: evidence via spatiotemporal expression analysis of p53 , p21 , MDM2 , IGF-1 , Gadd45 , Fas , and Akt
Qian, B., Qi, X., Bai, Y., & Wu, Y. (2020) · PeerJ · doi:10.7717/peerj.10532 · Cited by 18
Combining ReACp53 with Carboplatin to Target High-Grade Serous Ovarian Cancers
Neal, A. S., Lai, T. S., Singh, T., Rahseparian, N., Grogan, T., Elashoff, D. A., Scott, P., Pellegrini, M. A., & Memarzadeh, S. (2021) · Cancers · doi:10.3390/cancers13235908 · Cited by 18
Recent Advancements in the Discovery of MDM2/MDM2-p53 Interaction Inhibitors for the Treatment of Cancer
Bhatia, N., Khator, R., Kulkarni, S., Singh, Y., Kumar, P., & Thareja, S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867330666221114103924 · Cited by 19
Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer
Pang, L., Wang, Q., Wang, L., Hu, Z., Yang, C., Li, Y., Wang, Z., & Li, Y. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01487-x · Cited by 18
The G protein-coupled receptor GPRC5A—a phorbol ester and retinoic acid-induced orphan receptor with roles in cancer, inflammation, and immunity
González, P. A. I., Valdivieso, Á. G., & Santa-Coloma, T. A. (2023) · Biochemistry and Cell Biology · doi:10.1139/bcb-2022-0352 · Cited by 18
Accumulated CO2 affects growth, acid-base regulation and ion balance of turbot (Scophthalmus maximus) in a recirculating aquaculture system
Guo, T., Wang, Y., Li, J., Guo, X., Xu, S., Han, H., Yu, J., Li, J., & Liu, Q. (2023) · Aquaculture · doi:10.1016/j.aquaculture.2023.740070 · Cited by 18
Actinomycin D synergizes with Doxorubicin in triple-negative breast cancer by inducing P53-dependent cell apoptosis
Yang, H., Li, S., Li, W., Yang, Y., Zhang, Y., Zhang, S., Yue, H., Cao, W., Xu, F., Wang, H., et al. (2023) · Carcinogenesis · doi:10.1093/carcin/bgad086 · Cited by 18
Excessive MYC-topoisome activity triggers acute DNA damage, MYC degradation, and replacement by a p53-topoisome
Das, S., Karmakar, S., Venkatachalapathy, H., Jha, R., Batchelor, E., & Levens, D. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.10.006 · Cited by 18
Mining protein interactomes to improve their reliability and support the advancement of network medicine
Alanis‐Lobato, G. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00296 · Cited by 19
Asymmetric Cell Division and Template DNA Co-Segregation in Cancer Stem Cells
Pine, S. R., & Liu, W. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00226 · Cited by 20
Involvement of miR-15a in G0/G1 Phase Cell Cycle Arrest Induced by Porcine Circovirus Type 2 Replication
Quan, R., Wei, L., Zhu, S., Wang, J., Cao, Y., Xue, C., Yan, X., & Liu, J. (2016) · Scientific Reports · doi:10.1038/srep27917 · Cited by 18
Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells
Grespi, F., Landré, V., Molchadsky, A., Daniele, N. D., Marsella, L., Melino, G., & Rotter, V. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.419 · Cited by 18
Suppression of p53 potentiates chemosensitivity in nutrient-deprived cholangiocarcinoma cells via inhibition of autophagy
Hu, F., Guo, X., Zhang, S., Zhao, Q., Li, R., Xu, Q., & Wei, L. (2017) · Oncology Letters · doi:10.3892/ol.2017.6449 · Cited by 18
Interplay between p53 and Ink4c in spermatogenesis and fertility
Zalzali, H., Rabeh, W., Najjar, O., Ammar, R. A., Harajly, M., & Saab, R. H. (2018) · Cell Cycle · doi:10.1080/15384101.2017.1421874 · Cited by 18
Potential implications of hydrogen peroxide in the pathogenesis and therapeutic strategies of gliomas
Zhou, Y., Wang, L., Wang, C., Wu, Y., Chen, D., & Lee, T. H. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01205-6 · Cited by 19
From Bench to Bedside and Beyond: Therapeutic Scenario in Acute Myeloid Leukemia
Gurnari, C., Voso, M. T., Maciejewski, J. P., & Visconte, V. (2020) · Cancers · doi:10.3390/cancers12020357 · Cited by 18
Cooperation between oncogenic Ras and wild-type p53 stimulates STAT non-cell autonomously to promote tumor radioresistance
Dong, Y.-L., Vadla, G. P., Lu, J., Ahmad, V., Klein, T. J., Liu, L., Glazer, P. M., Xu, T., & Chabu, C. Y. (2021) · Communications Biology · doi:10.1038/s42003-021-01898-5 · Cited by 21
Prognostic and Predictive Models for Left- and Right- Colorectal Cancer Patients: A Bioinformatics Analysis Based on Ferroptosis-Related Genes
Chen, Y., & Li, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.833834 · Cited by 18
NKX2-1-mediated p53 expression modulates lung adenocarcinoma progression via modulating IKKβ/NF-κB activation
Chen, P.-M., Wu, T., Cheng, Y., Chen, C., & Lee, H. (2015) · Oncotarget · doi:10.18632/oncotarget.3695 · Cited by 18
TAp73 transcriptionally represses BNIP3 expression
Petrova, V., Mancini, M., Agostini, M., Knight, R. A., Annicchiarico‐Petruzzelli, M., Barlev, N. A., Melino, G., & Amelio, I. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1044178 · Cited by 18
Analysis of an ankyrin-like region in Epstein Barr Virus encoded (EBV) BZLF-1 (ZEBRA) protein: implications for interactions with NF-κB and p53
Dreyfus, D. H., Liu, Y., Ghoda, L. Y., & Chang, J. T. (2011) · Virology Journal · doi:10.1186/1743-422x-8-422 · Cited by 18
Targeted Knockdown of the Kinetochore Protein D40/Knl-1 Inhibits Human Cancer in a p53 Status-Independent Manner
Urata, Y. N., Takeshita, F., Tanaka, H., Ochiya, T., & Takimoto, M. (2015) · Scientific Reports · doi:10.1038/srep13676 · Cited by 20
Analysis of TRRAP as a Potential Molecular Marker and Therapeutic Target for Breast Cancer
Ji, W., Shan, M., Liu, T., Shi, Q., Zhong, Z., Wei, W., & Pang, D. (2016) · Journal of Breast Cancer · doi:10.4048/jbc.2016.19.1.61 · Cited by 18
Alteration of classical and hematopoiesis specific p53 pathway in the bone marrow hematopoietic stem/progenitor compartment facilitates leukemia progression in experimental mice
Chatterjee, R., Chattopadhyay, S., & Law, S. K. A. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.05.014 · Cited by 18
Lysines in the tetramerization domain of p53 selectively modulate G1 arrest
Beckerman, R., Yoh, K. E., Mattia-Sansobrino, M., Zupnick, A., Laptenko, O., Karni-Schmidt, O., Ahn, J., Byeon, I. L., Keezer, S. M., & Prives, C. L. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1170270 · Cited by 19
The small molecule AU14022 promotes colorectal cancer cell death via p53‐mediated G2/M‐phase arrest and mitochondria‐mediated apoptosis
Ryu, H., Nam, K., Kim, J., Hwang, S., Song, J. Y., & Ahn, J. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26234 · Cited by 18
Molecular Pathology of Prostate Cancer
Kulaç, İ., Roudier, M. P., & Haffner, M. C. (2024) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2023.08.003 · Cited by 19
Epigenetic Priming with Decitabine Augments the Therapeutic Effect of Cisplatin on Triple-Negative Breast Cancer Cells through Induction of Proapoptotic Factor NOXA
Nakajima, W., Miyazaki, K., Sakaguchi, M., Asano, Y., Ishibashi, M., Kurita, T., Yamaguchi, H., Takei, H., & Tanaka, N. (2022) · Cancers · doi:10.3390/cancers14010248 · Cited by 17
Potential of rescue and reactivation of tumor suppressor p53 for cancer therapy
Hibino, E., & Hiroaki, H. (2022) · Biophysical Reviews · doi:10.1007/s12551-021-00915-5 · Cited by 17
Functional Domains of the Early Proteins and Experimental and Epidemiological Studies Suggest a Role for the Novel Human Polyomaviruses in Cancer
Moens, U. L., Prezioso, C., & Pietropaolo, V. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.834368 · Cited by 18
Mimicking p14ARF Phosphorylation Influences Its Ability to Restrain Cell Proliferation
Vivo, M., Ranieri, M., Sansone, F., Santoriello, C., Calogero, R., Calabrò, V., Pollice, A., & Mantia, G. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053631 · Cited by 19
GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial
Cryer, B., Li, C., Simon, L. S., Singh, G., Stillman, M. J., & Berger, M. F. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3664 · Cited by 17
Effect of testosterone on the regulation of p53 and p66Shc during oxidative stress damage in C2C12 cells
Pronsato, L., & Milanesi, L. M. (2015) · Steroids · doi:10.1016/j.steroids.2015.12.007 · Cited by 17
The high expression instead of mutation of p53 is predictive of overall survival in patients with esophageal squamous‐cell carcinoma: a meta‐analysis
Zhao, Z., Wang, P., Gao, Y., & He, J. (2016) · Cancer Medicine · doi:10.1002/cam4.945 · Cited by 17
Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma
Dhieb, D., Belguith, I., Capelli, L., Chiadini, E., Canale, M., Bravaccini, S., Yangui, I., Boudawara, O., JLIDI, R., Boudawara, T. S., et al. (2019) · Cells · doi:10.3390/cells8060514 · Cited by 17
E3 ubiquitin ligase MDM2 acts through p53 to control respiratory progenitor cell number and lung size
Sui, P., Li, R., Zhang, Y., Tan, C., Garg, A., Verheyden, J. M., & Sun, X. (2019) · Development · doi:10.1242/dev.179820 · Cited by 17
Par-4 regulates autophagic cell death in human cancer cells via upregulating p53 and BNIP3
Thayyullathil, F., Cheratta, A. R., Pallichankandy, S., Subburayan, K., Tariq, S., Rangnekar, V. M., & Galadari, S. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118692 · Cited by 17
The Undervalued Avenue to Reinstate Tumor Suppressor Functionality of the p53 Protein Family for Improved Cancer Therapy-Drug Repurposing
Zawacka‐Pankau, J. (2020) · Cancers · doi:10.3390/cancers12092717 · Cited by 16
Length variants of the 5′ untranslated region of p53 mRNA and their impact on the efficiency of translation initiation of p53 and its N-truncated isoform ΔNp53
Gorska, A. A., Błaszczyk, L., Dutkiewicz, M., & Ciesiołka, J. (2013) · RNA Biology · doi:10.4161/rna.26562 · Cited by 18
BRIT1 regulates p53 stability and functions as a tumor suppressor in breast cancer
Zhang, B., Wang, E., Dai, H., Hu, R., Liang, Y., Li, K., Wang, G., Peng, G., & Lin, S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt190 · Cited by 17
AIMP3 depletion causes genome instability and loss of stemness in mouse embryonic stem cells
Kim, S. M., Jeon, Y., Kim, D., Jang, H., Bae, J. S., Park, M. K., Kim, H., Kim, S., & Lee, H. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1037-4 · Cited by 17
Simultaneous determination of two phosphorylated p53 proteins in SCC-7 cells by an ICP-MS immunoassay using apoferritin-templated europium(III) and lutetium(III) phosphate nanoparticles as labels
Yin, X., Chen, B., He, M., & Hu, B. (2019) · Microchimica Acta · doi:10.1007/s00604-019-3540-4 · Cited by 17
Inhibition of tumor suppressor p73 by nerve growth factor receptor via chaperone-mediated autophagy
Nguyen, D., YANG, K. Y., Chiao, L. J., Deng, Y., Zhou, X. Y., Zhang, Z., Zeng, S. X., & Lu, H. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa017 · Cited by 18
Molecular Pathology of Prostate Cancer
Kulaç, İ., Roudier, M. P., & Haffner, M. C. (2021) · Surgical pathology clinics · doi:10.1016/j.path.2021.05.004 · Cited by 17
The expression ofp53-regulated genes in human cultured lymphoblastoid TSCE5 and WTK1 cell lines during spaceflight
Takahashi, A., Suzuki, H., Omori, K., Seki, M., Hashizume, T., Shimazu, T., Ishioka, N., & Ohnishi, T. (2010) · International Journal of Radiation Biology · doi:10.3109/09553001003789596 · Cited by 17
Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma
Ikeda, S., Hansel, D. E., & Kurzrock, R. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.06.004 · Cited by 16
Noncoding RNAs in apoptosis: identification and function
Tüncel, Ö., Kara, M., Yaylak, B., Erdoğan, İ., & Akgül, B. (2021) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-2109-35 · Cited by 16
Structural basis of bacterial effector protein azurin targeting tumor suppressor p53 and inhibiting its ubiquitination
Hu, J., Jiang, W., Zuo, J., Shi, D., Chen, X., Yang, X., Zhang, W., Ma, L., Liu, Z., & Xing, Q. (2023) · Communications Biology · doi:10.1038/s42003-023-04458-1 · Cited by 17
Protein Diffusion Along Protein and DNA Lattices: Role of Electrostatics and Disordered Regions
Bigman, L. S., & Levy, Y. (2023) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-111622-091220 · Cited by 17
LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation
Ali, A., Grillone, K., Ascrizzi, S., Caridà, G., Fiorillo, L., Ciliberto, D., Staropoli, N., Tagliaferri, P., Tassone, P., & Martino, M. T. D. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102221 · Cited by 18
mTOR and SGLT-2 Inhibitors: Their Synergistic Effect on Age-Related Processes
Troise, D. E., Mercuri, S., Infante, B., Losappio, V., Cirolla, L. A., Netti, G. S., Ranieri, E., & Stallone, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168676 · Cited by 17
Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy
Majumdar, G., Rooney, R. J., Johnson, I. M., & Raghow, R. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00048.2011 · Cited by 16
BAG3 down-modulation sensitizes HPV18+ HeLa cells to PEITC-induced apoptosis and restores p53
Cotugno, R., Basile, A. M., Romano, E., Gallotta, D., & Belisario, M. A. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.08.022 · Cited by 16
Is now the time for molecular driven therapy for diffuse large B-cell lymphoma?
Rocco, A. D., Angelis, F. D., Ansuinelli, M., Foà, R., & Martelli, M. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1356714 · Cited by 16
The Role of Chromosome Deletions in Human Cancers
Chen, M., Yang, Y., Liu, Y., & Chen, C. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0593-1_9 · Cited by 16
Role of estrogen receptors, P450 aromatase, PCNA and p53 in high-fat-induced impairment of spermatogenesis in rats
Verderame, M., Migliaccio, V., & Scudiero, R. (2018) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2018.07.002 · Cited by 16
TP53 and therapy-related myeloid neoplasms
Chung, J., Sallman, D. A., & Padron, E. (2019) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2019.02.009 · Cited by 16
WW Domain-Containing E3 Ubiquitin Protein Ligase 1: A Self-Disciplined Oncoprotein
Kuang, L., Jiang, Y., Li, C., & Jiang, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.757493 · Cited by 16
Pharmacokinetics and metabolism of AMG 232, a novel orally bioavailable inhibitor of the MDM2–p53 interaction, in rats, dogs and monkeys:in vitro–in vivocorrelation
Ye, Q., Jiang, M., Huang, W. T., Ling, Y., Olson, S. H., Sun, D., Xu, G., Yan, X., Wong, B. K., & Jin, L. (2015) · Xenobiotica · doi:10.3109/00498254.2015.1010632 · Cited by 16
Investigation of Genetic Polymorphisms Related to the Outcome of Radiotherapy for Prostate Cancer Patients
de Paula, H. D. S. C., Pinezi, J. C. D., Machado, G. D. P., de Carvalho, G. M., Carvalho, A. T. S., dos Santos, T. E. D., Marciano, R. D., & Soares, R. D. B. A. (2013) · Disease Markers · doi:10.1155/2013/762685 · Cited by 16
Combination of 9-aminoacridine with Campath-1H provides effective therapy for a murine model of adult T-cell leukemia
Ju, W., Zhang, M., Petrus, M. N., Maeda, M., Pise-Masison, C. A., & Waldmann, T. A. (2014) · Retrovirology · doi:10.1186/1742-4690-11-43 · Cited by 18
The association between exposure to aflatoxin, mutation in TP53, infection with hepatitis B virus, and occurrence of liver disease in a selected population in Hyderabad, India
Anitha, S., Digumarti, R., Waliyar, F., Sudini, H., Parveen, M., Rao, R., & Kumar, P. L. (2014) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2013.12.011 · Cited by 16
Intracellular Delivery of ERBB2 siRNA and p53 Gene Synergistically Inhibits the Growth of Established Tumor in an Immunocompetent Mouse
Kunnath, A. P. (2014) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000256 · Cited by 16
p53 elevation in human cells halt SV40 infection by inhibiting T-ag expression
Drayman, N., Ben-nun-Shaul, O., Butin‐Israeli, V., Srivastava, R., Rubinstein, A. M., Mock, C. S., Elyada, E., Ben‐Neriah, Y., Lahav, G., & Oppenheim, A. (2016) · Oncotarget · doi:10.18632/oncotarget.10769 · Cited by 17
p53, p63 and p73 in the wonderland ofS. cerevisiae
Billant, O., Blondel, M., & Voisset, C. (2017) · Oncotarget · doi:10.18632/oncotarget.18506 · Cited by 16
Identification of an alternatively spliced nuclear isoform of human N-terminal acetyltransferase Naa30.
Varland, S., Myklebust, L. M., Goksøyr, S. Ø., Glomnes, N., Torsvik, J., Varhaug, J., & Arnesen, T. (2018) · Gene · doi:10.1016/j.gene.2017.12.019 · Cited by 15
Trichostatin A induces p53‑dependent endoplasmic reticulum stress in human colon cancer cells
Dai, L., He, G., Zhang, K., Guan, X., Wang, Y., & Zhang, B. (2018) · Oncology Letters · doi:10.3892/ol.2018.9641 · Cited by 16
Prognostic Effect of TP53 and PKD Co-Mutations in Patients with Resected Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma
Liu, D., Zhao, Z.-R., Lin, Y., Zhou, W., Hou, J., Ye, Z., & Long, H. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07254-6 · Cited by 16
Pathology and Genetics
Ornellas, A. A., Alves, G., & Schwindt, A. B. D. S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0461-7_4 · Cited by 17
A link between TP53 polymorphisms and metabolism
Kung, C.-P., Basu, S., & Murphy, M. E. (2016) · Molecular & Cellular Oncology · doi:10.1080/23723556.2016.1173769 · Cited by 16
Epigenetic regulation of iron metabolism and ferroptosis in Parkinson’s disease: Identifying novel epigenetic targets
Gao, X., Ding, J.-E., Xie, J., & Xu, H. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01499-6 · Cited by 15
CSB modulates the competition between HIF-1 and p53 upon hypoxia
Ye, X.-W., Zhang, X., & Liu, F. (2019) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2019262 · Cited by 16

Authors: Levine, A. J., & Oren, M.
Affiliations: Institute for Advanced Study (US)
Weizmann Institute of Science (IL)
ORCID: Levine, Arnold J.
Oren, Moshe
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2009-10
Volume: 9
Issue: 10
Pages: 749-758
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc2723
PMC: PMC2771725
OpenAlex: W1966163762
Cited by: 1,967
References: 169
Citations by year: 2026: 64 · 2025: 111 · 2024: 107 · 2023: 112 · 2022: 114 · 2021: 129 · 2020: 128 · 2019: 111 · 2018: 127 · 2017: 120 · 2016: 144 · 2015: 115 · 2014: 150 · 2013: 113 · 2012: 170
FWCI: 9.34
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (P01CA087497, R37 CA40099, R37CA040099, P01CA87497.)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords: p53, TP53, tumour suppressor, SV40 large T antigen, transcription factors, cell cycle arrest, apoptosis, cellular senescence, metabolic regulation, cytokine regulation, embryo implantation
MeSH terms: Animals, Humans, Neoplasms, Genes, p53, Tumor Suppressor Protein p53, History, 20th Century, History, 21st Century

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The first 30 years of p53: growing ever more complex.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks